ZA872972B - Benzothiazinone derivatives,processes for their preparation,medicaments containing them and their use - Google Patents

Benzothiazinone derivatives,processes for their preparation,medicaments containing them and their use

Info

Publication number
ZA872972B
ZA872972B ZA872972A ZA872972A ZA872972B ZA 872972 B ZA872972 B ZA 872972B ZA 872972 A ZA872972 A ZA 872972A ZA 872972 A ZA872972 A ZA 872972A ZA 872972 B ZA872972 B ZA 872972B
Authority
ZA
South Africa
Prior art keywords
processes
preparation
medicaments containing
benzothiazinone derivatives
benzothiazinone
Prior art date
Application number
ZA872972A
Other languages
English (en)
Inventor
Ulrich Lerch
Lerch Ulrich
Rainer Henning
Henning Rainer
Joachim Kaiser
Kaiser Joachim
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA872972B publication Critical patent/ZA872972B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA872972A 1986-04-28 1987-04-27 Benzothiazinone derivatives,processes for their preparation,medicaments containing them and their use ZA872972B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863614363 DE3614363A1 (de) 1986-04-28 1986-04-28 Benzothiazinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung

Publications (1)

Publication Number Publication Date
ZA872972B true ZA872972B (en) 1987-11-25

Family

ID=6299713

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872972A ZA872972B (en) 1986-04-28 1987-04-27 Benzothiazinone derivatives,processes for their preparation,medicaments containing them and their use

Country Status (13)

Country Link
EP (1) EP0244723A3 (no)
JP (1) JPS62258371A (no)
KR (1) KR870010028A (no)
AU (1) AU601659B2 (no)
DE (1) DE3614363A1 (no)
DK (1) DK213387A (no)
FI (1) FI871813A (no)
HU (1) HU199814B (no)
IL (1) IL82332A (no)
NO (1) NO871745L (no)
NZ (1) NZ220100A (no)
PT (1) PT84770B (no)
ZA (1) ZA872972B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6534509B1 (en) 1997-06-12 2003-03-18 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3724366A1 (de) * 1987-07-23 1989-02-02 Hoechst Ag Benzothiazinon-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
DE3726759A1 (de) * 1987-08-12 1989-03-09 Hoechst Ag Benzothiazinon-oxide, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung sowie zwischenprodukte zu ihrer herstellung
CA2032487A1 (en) * 1989-06-16 1990-12-17 Yasufumi Shirasaki Noortopic agent
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
BRPI0404222A (pt) * 2004-06-07 2006-02-07 Fundacao Oswaldo Cruz Compostos derivados da lidocaìna, composições farmacêuticas contendo os mesmos, uso das respectivas composições farmacêuticas no tratamento, prevenção ou inibição de doenças bem como o método de tratamento, prevenção ou inibição de doenças com as ditas composições farmacêuticas
BR112016028081A2 (pt) * 2014-05-30 2017-08-22 Sphaera Pharma Private Ltd Novos compostos como agentes antituberculares

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
JPS59148771A (ja) * 1983-02-09 1984-08-25 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
DE3347173A1 (de) * 1983-12-27 1985-07-04 Hoechst Ag, 6230 Frankfurt Neue benzothiazin-derivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung
EP0186310A1 (en) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. 1,4-Benzothiazine Derivatives, their production and use
EP0233291B1 (en) * 1985-03-19 1991-03-13 Santen Pharmaceutical Co., Ltd. 2-arylbenzothiazine derivatives
KR890004196B1 (ko) * 1985-07-29 1989-10-27 산텐세이야꾸가부시끼가이샤 신규 벤조티아진 유도체의 제조방법

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6534509B1 (en) 1997-06-12 2003-03-18 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6541476B1 (en) 1997-06-12 2003-04-01 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6555537B2 (en) 1997-06-12 2003-04-29 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6573266B1 (en) 1997-06-12 2003-06-03 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6972290B2 (en) 1997-06-12 2005-12-06 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6977258B2 (en) 1997-06-12 2005-12-20 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US7268140B2 (en) 1997-06-12 2007-09-11 Schering Ag Piperazine derivatives and their use as anti-inflammatory agents

Also Published As

Publication number Publication date
EP0244723A3 (de) 1988-10-19
EP0244723A2 (de) 1987-11-11
PT84770A (de) 1987-05-01
JPS62258371A (ja) 1987-11-10
DK213387A (da) 1987-10-29
NO871745L (no) 1987-10-29
HUT45517A (en) 1988-07-28
AU601659B2 (en) 1990-09-13
FI871813A0 (fi) 1987-04-24
DE3614363A1 (de) 1987-10-29
KR870010028A (ko) 1987-11-30
FI871813A (fi) 1987-10-29
HU199814B (en) 1990-03-28
IL82332A (en) 1991-08-16
AU7199487A (en) 1987-10-29
PT84770B (pt) 1989-12-29
IL82332A0 (en) 1987-10-30
DK213387D0 (da) 1987-04-27
NZ220100A (en) 1990-03-27
NO871745D0 (no) 1987-04-27

Similar Documents

Publication Publication Date Title
IL83198A (en) Benzenesulphonamidoindanyl derivatives,their preparation and medicaments containing them
IL81184A0 (en) Diarylalkyl-substituted alkylamines,processes for their preparation,their use,and medicaments containing them
IL79457A0 (en) Tertiary hydroxyalkylxanthines,processes for their preparation,medicaments containing them and their use
IL84522A0 (en) Imidazopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GR3002636T3 (en) Pyrimidine derivatives, their preparation and medicaments containing these derivatives
GR860849B (en) 4-demethyl -4- epipodophyllotoxin derivatives process for their preparation and their use as medicaments
IL83152A0 (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes,a process for their preparation,and their use as medicaments
IL84913A0 (en) Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
AR242389A1 (es) Procedimiento para preparar -di-(n-alquil c1-c4)-amino-4,5-dihidroimidazo¡1,2-a¿quinazolin-2(1h)-onas.
ZA866529B (en) Azolyl-cyclopropyl-ethanol derivatives,processes for their preparation and their use
EP0255894A3 (en) Pyrimidine derivatives, their preparation and medicaments containing them
ZA85487B (en) Azolyl-aryl-alkanol derivatives,processes for their preparation and their use
GB2186573B (en) Purine derivatives, their preparation and medicaments containing them
EP0256400A3 (en) Pyrimidine derivatives, their preparation and medicaments containing these derivatives
ZA872972B (en) Benzothiazinone derivatives,processes for their preparation,medicaments containing them and their use
ZA872975B (en) Novel benzothiazinone derivatives,processes for their preparation,medicaments containing them and their use
ZA871756B (en) Arylazolylmethylbenzocycloalkene derivatives,processes for the preparation thereof,and the use thereof
ZA865332B (en) Dihydroquinolinone derivatives,processes for their preparation,medicaments containing them and their use,and intermediate products for their preparation
ZA872443B (en) Bis-tert.butylamino-substituted 1,3,5-triazine derivatives,processes for their preparation,medicaments containing these compounds and their use
ZA876595B (en) Isoprene derivatives
ZA879706B (en) New alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
NZ221769A (en) Medicaments containing sialocylglycerolipid
NZ220805A (en) Cytorhodin s derivatives,a process for their preparation and their use as medicaments
EP0267537A3 (en) Process for the preparation of vinylglyoxal derivatives, vinylglyoxal derivatives and their use